Overview


According to FutureWise analysis the market for respiratory devices in 2023 is US$ 24.2 billion, and is expected to reach US$ 47.94 billion by 2031 at a CAGR of 8.90%

Respiratory devices are used to help patients with breathing difficulties by enhancing pulmonary functioning and helps in clearing mucus from the airways. These tools are used to control and treat conditions like Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Fibrosis and Asthma. Given the increased need for respiratory devices as a result of the increase in pollution levels along with COVID-19 pandemic, the market for respiratory devices will have greater room for expansion.

Respiratory diseases are expected to be more common as the world's population matures. Additionally, chronic conditions like COPD and asthma will spread more widely. As a result, the demand for breathing equipment will rise steadily. In recent years, a variety of gadgets have been used by patients with lung illnesses to help clear mucus from the airways and enhance pulmonary performance. The high incidence of respiratory illnesses, ageing populations worldwide, the high rate of smoking, pollution, the increase in preterm births, and alterations in lifestyle are the main factors driving the development of the global respiratory devices market. The need for respiratory treatment immediately rises as a consequence of infectious respiratory illnesses. The market for anaesthesia and breathing equipment has been significantly impacted by the rise in respiratory illnesses like Obstructive Sleep Apnea (OSA). Due to the high incidence of respiratory illnesses, respiratory devices predominate in the market.

Patients using respiratory aids are able to breathe enough oxygen to sustain life while having respiratory issues. Asthma, chronic obstructive pulmonary disease (COPD), TB, and pneumonia are just a few examples of the respiratory disorders that can be diagnosed, monitored, and treated with respiratory care devices. Patients with acute and long-term respiratory illnesses benefit from the improved quality of care these devices offer. With the ageing of the world population and the exponential rise in the prevalence of chronic diseases like COPD and asthma, the prevalence of respiratory illnesses will only continue to rise. Furthermore, there will be an increase in demand for respiratory devices. Various devices that help clear mucus from the airways and enhance pulmonary function have been employed recently by patients with respiratory disorders.

FutureWise Market Research has published a report that provides an insightful analysis of Respiratory Devices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Respiratory Devices Market will experience a significant growth. According to the analysis done this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic, and expansion decisions by key stakeholders of an organisation.

  • ResMed, Inc.
  • Smiths Medical
  • Fisher & Paykel Healthcare Limited
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • Getinge AB
  • Medtronic plc
  • Koninklijke Philips N.V.
  • Chart Industries
  • Vyaire Medical, Inc.
  • Karl Storz GmbH & Co. KG
  • 3B Medical, Inc.
  • Medline Industries Inc.
  • Acare Technology Co., Ltd.
  • Allied Healthcare Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Therapeutic Devices
    • Drug Delivery Devices
      • Nebulizers
      • Inhalers
    • Mechanical Ventilators
      • Invasive
      • Non-Invasive
    • Continuous Positive Airway Pressure
      • Devices
      • Disposables
    • Resuscitators
      • Reusable
      • Disposables
    • Humidifiers
    • Airway Clearance Devices
    • Oxygen Concentrators
    • Consumables & Disposables
    • Others
  • Diagnostic & Monitoring Devices
    • Pulse Oximeters
    • Capnography
    • Spirometers
    • Polysomnography
    • Peak Flow Meters
    • Gas Analyzers
    • Others

By Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia

By End User

  • Hospitals/ Clinics
  • Homecare Settings
  • Other End-Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. North America has an influential position in the respiratory devices industry due to the region's high prevalence of COPD, tuberculosis, asthma, and sleep apnea. For instance, the CDC's 2022 report states that in the United States in 2021, 4.6% of individuals aged 18 and older had COPD, emphysema, or chronic bronchitis. Because of this, market development is anticipated over the upcoming few years due to the high prevalence of respiratory illnesses in the US. Additionally, the development of technologically innovative products, product launches, and collaborations are driving a substantial increase in the market in North America. Top companies that hold majority share in the market are Medtronic PLC, Teleflex Incorporated, Hamilton Medical, Smiths Group Plc, and General electric. These companies all together hold 63.4% global market share in 2022.


  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Respiratory Device Market By Type, By Application, By End-user and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Respiratory Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Respiratory Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Respiratory Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Respiratory Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Therapeutic Devices
         1.1. Drug Delivery Devices
          1.1.1. Nebulizers
          1.1.2. Inhalers
         1.2. Mechanical Ventilators
          1.2.1. Invasive
          1.2.2. Non-Invasive
         1.3. Continuous Positive Airway Pressure
          1.3.1. Devices
          1.3.2. Disposables
         1.4. Resuscitators
          1.4.1. Reusable
          1.4.2. Disposables
         1.5. Humidifiers
         1.6. Airway Clearance Devices
         1.7. Oxygen Concentrators
         1.8. Consumables & Disposables
         1.9. Others
        2. Diagnostic & Monitoring Devices
         2.1. Pulse Oximeters
         2.2. Capnography
         2.3. Spirometers
         2.4. Polysomnography
         2.5. Peak Flow Meters
         2.6. Gas Analyzers
         2.7. Others

  • 8.   Respiratory Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chronic Obstructive Pulmonary Disease
        2. Asthma
        3. Obstructive Sleep Apnea
        4. Respiratory Distress Syndrome
        5. Cystic Fibrosis
        6. Pneumonia

  • 9.   Respiratory Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals/ Clinics
        2. Homecare Settings
        3. Other End-User

  • 10.   North America Respiratory Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Respiratory Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Respiratory Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Respiratory Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ResMed, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Smiths Medical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fisher & Paykel Healthcare Limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Dragerwerk AGCo. KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GE Healthcare
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Getinge AB
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
         8. Koninklijke Philips N.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Chart Industries
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Vyaire Medical, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Karl Storz GmbHCo. KG
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. 3B Medical, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Medline Industries Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Acare Technology Co., Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Allied Healthcare Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients